Ruiming Xinyao
Latest round
- Series B
Last raised
- Apr 2022
Total raised
- Undisclosed
Investors
- 10
About Ruiming Xinyao
Based in Suzhou, China, and established in 2018, Ruiming Xinyao operates as a pharmaceutical company that focuses on developing small molecule new drugs for the treatment of ophthalmic diseases. The company's team members are from pharmaceutical companies, such as Novartis and Alcon, who have experience in new drugs development and drug launches. The company's products lines covered the fields of ophthalmology vascular lesions and ophthalmology neurological lesions. The ophthalmology vascular lesions include Age-related wet macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema. The ophthalmology neurological lesions include glaucoma. The form of drug delivery is eye drop, which replaced the previous injection into the vitreous.
Who invested in Ruiming Xinyao
10 investors across 4 rounds
See all investors in Ruiming Xinyao
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ruiming Xinyao
Who invested in Ruiming Xinyao?
Ruiming Xinyao has 10 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ruiming Xinyao raised?
Ruiming Xinyao has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Ruiming Xinyao last raise money?
Ruiming Xinyao's most recent round on record is a Series B, in Apr 2022.
What does Ruiming Xinyao do?
Based in Suzhou, China, and established in 2018, Ruiming Xinyao operates as a pharmaceutical company that focuses on developing small molecule new drugs for the treatment of ophthalmic diseases.
Where is Ruiming Xinyao headquartered?
Ruiming Xinyao is headquartered in Suzhou, China.
Which VCs invest in companies like Ruiming Xinyao?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at Ruiming Xinyao's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Ruiming Xinyao? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.